GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 208 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $48,707,000 | +52.8% | 1,524,485 | +65.7% | 0.21% | +62.2% |
| Q1 2022 | $31,876,000 | +493.6% | 920,200 | +401.6% | 0.13% | +504.8% |
| Q4 2021 | $5,370,000 | -93.6% | 183,471 | -94.5% | 0.02% | -94.3% |
| Q3 2021 | $84,405,000 | -21.3% | 3,312,600 | +8.2% | 0.37% | -22.9% |
| Q2 2021 | $107,217,000 | +98.5% | 3,061,600 | +131.0% | 0.48% | +90.9% |
| Q1 2021 | $54,013,000 | +2266.9% | 1,325,482 | +2416.1% | 0.25% | +2190.9% |
| Q4 2020 | $2,282,000 | -17.2% | 52,680 | +5.4% | 0.01% | -21.4% |
| Q3 2020 | $2,757,000 | -79.6% | 50,000 | -76.6% | 0.01% | -84.1% |
| Q2 2020 | $13,517,000 | -7.9% | 214,113 | -25.5% | 0.09% | -26.1% |
| Q1 2020 | $14,684,000 | -74.2% | 287,417 | -59.8% | 0.12% | -60.1% |
| Q4 2019 | $56,810,000 | +65.4% | 714,681 | +1.0% | 0.30% | +41.2% |
| Q3 2019 | $34,343,000 | -34.6% | 707,808 | -39.1% | 0.21% | +0.5% |
| Q2 2018 | $52,550,000 | +335.2% | 1,162,600 | +365.0% | 0.21% | +320.0% |
| Q1 2018 | $12,075,000 | -28.0% | 250,000 | -41.4% | 0.05% | -30.6% |
| Q4 2017 | $16,775,000 | -73.3% | 426,300 | -78.9% | 0.07% | -74.3% |
| Q3 2017 | $62,805,000 | +228.6% | 2,022,700 | +189.5% | 0.28% | +161.7% |
| Q2 2017 | $19,111,000 | +26.2% | 698,766 | +70.0% | 0.11% | +27.4% |
| Q1 2017 | $15,149,000 | +750.6% | 411,100 | +266.1% | 0.08% | +500.0% |
| Q1 2016 | $1,781,000 | – | 112,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |